Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Deo

Showing results (191-200 of 287) with videos related to

Pageof 29
Sort By:
Australasian Radiology|March 22, 2001
Attitudes and treatment outcome of breast conservation therapy for stage I & II breast cancer using peroperative iridium-192 implant boost to the tumour bedS S Deo, B K Mohanti, N K Shukla, et al.
Technology in Cancer Research & Treatment|February 17, 2026
β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939Sheikh Mohammad Umar, Shruti Kahol, Sandeep R Mathur, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|May 12, 2016
Nonrhabdomyosarcomatous abdominopelvic sarcomas: Analysis of prognostic factorsNida Iqbal, Nootan K Shukla, S V S Deo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosisShilpi Arora, Jatinder Kaur, Chavvi Sharma, et al.
Experimental Cell Research|September 13, 2020
Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancerSheikh Mohammad Umar, Akanksha Kashyap, Shruti Kahol, et al.
Indian Journal of Cancer|January 21, 2011
Outcome of combined modality treatment including neoadjuvant chemotherapy of 128 cases of locally advanced breast cancer: data from a tertiary cancer center in northern IndiaV Raina, M Kunjahari, N K Shukla, et al.
The Malaysian Journal of Pathology|April 20, 2015
Role of directional vacuum assisted breast biopsy in previously equivocal biopsies for breast masses suspicious for malignancyU Debi, S Thulkar, S Sharma, et al.
The Journal of the Association of Physicians of India|July 4, 2003
Intent of therapy in metastatic breast cancer with isolated ipsilateral supraclavicular lymph node spread--a therapeutic dilemmaS V S Deo, J Purkayastha, N K Shukla, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 6, 2015
Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patientsN Iqbal, N K Shukla, S V S Deo, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 17, 2014
Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North IndiaShilpi Chattopadhyay, Sarah Siddiqui, Md Salman Akhtar, et al.
Pageof 29

Showing results (191-200 of 287) with videos related to

Sort By:
Pageof 29
Australasian Radiology|March 22, 2001
Attitudes and treatment outcome of breast conservation therapy for stage I & II breast cancer using peroperative iridium-192 implant boost to the tumour bedS S Deo, B K Mohanti, N K Shukla, et al.
Technology in Cancer Research & Treatment|February 17, 2026
β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939Sheikh Mohammad Umar, Shruti Kahol, Sandeep R Mathur, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|May 12, 2016
Nonrhabdomyosarcomatous abdominopelvic sarcomas: Analysis of prognostic factorsNida Iqbal, Nootan K Shukla, S V S Deo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosisShilpi Arora, Jatinder Kaur, Chavvi Sharma, et al.
Experimental Cell Research|September 13, 2020
Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancerSheikh Mohammad Umar, Akanksha Kashyap, Shruti Kahol, et al.
Indian Journal of Cancer|January 21, 2011
Outcome of combined modality treatment including neoadjuvant chemotherapy of 128 cases of locally advanced breast cancer: data from a tertiary cancer center in northern IndiaV Raina, M Kunjahari, N K Shukla, et al.
The Malaysian Journal of Pathology|April 20, 2015
Role of directional vacuum assisted breast biopsy in previously equivocal biopsies for breast masses suspicious for malignancyU Debi, S Thulkar, S Sharma, et al.
The Journal of the Association of Physicians of India|July 4, 2003
Intent of therapy in metastatic breast cancer with isolated ipsilateral supraclavicular lymph node spread--a therapeutic dilemmaS V S Deo, J Purkayastha, N K Shukla, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 6, 2015
Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patientsN Iqbal, N K Shukla, S V S Deo, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 17, 2014
Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North IndiaShilpi Chattopadhyay, Sarah Siddiqui, Md Salman Akhtar, et al.
Pageof 29